Toxicology Company Files Suit Against Competitor

US Health Group Inc. (USHG) is seeking a temporary restraining order and temporary injunction against Physicians Choice Laboratory Services (PCLS) and some of its employees, alleging that they … [Read more...]

J&J Receives Strict Corporate Integrity Agreement As Part of $2.2 Billion Settlement

In the third-largest settlement the government has reached with a pharmaceutical company, Johnson & Johnson (J&J) and two of its subsidiaries have agreed to pay $2.2 billion in fines and … [Read more...]

Audit Finds Three Major Deficiencies In Oversight of Security Rule

The Office for Civil Rights (OCR) would be cited for several major deficiencies if it were conducting one of its Health Insurance Portability and Accountability Act security rule audits on itself, … [Read more...]

Hospital Self-Discloses Improper Financial Arrangements

A Montana hospital and its parent company agreed to a $3.85 million settlement with the government to resolve allegations that they violated the anti-kickback statute, the physician self-referral … [Read more...]

News-At-A-Glance: Tuomey Healthcare System Files Stay

Tuomey Healthcare System (Sumter, S.C.) has filed a motion for stay of a $70 million payment in order to prevent bankruptcy, according to an April 9 order in U.S. District Court for the District of … [Read more...]

OIG Again Demonstrates Its Prowess in Bringing Fraudsters to Justice

Government agencies this month announced a nationwide takedown by Medicare Fraud Strike Force operations that involved six cities and charges against 90 individuals for their alleged participation in … [Read more...]

Compliance Perspectives: Keeping Legal Advice In-House: Protecting the Attorney-Client Privilege

Given that laboratories operate in a heavily regulated environment, the advice of legal counsel is integral to ensuring compliance with the many laws and regulations that govern the laboratory … [Read more...]

LabMD vs. FTC Trial Delayed Amid Dramatic Twists and Turns

The highly anticipated trial of LabMD versus the Federal Trade Commission (FTC) has been interrupted by a related investigation by the House Committee on Oversight and Government Reform. The … [Read more...]

G2 Compliance Perspectives: Implications for Clinical Laboratories In the OIG’s Proposal to Expand CMP Authority

There are potentially significant implications for the clinical laboratory industry in a proposed rule published in the Federal Register on May 12 that amends and expands the authority of the Office … [Read more...]

All False Claims Act Qui Tam Cases Will Get Criminal Reviews

Under a new Department of Justice (DOJ) process for qui tam complaints, all new civil complaints are reviewed by the criminal division as soon as they are filed to determine if a parallel criminal … [Read more...]